BioSpace News Archive

Providence, one of the largest health systems in the country, announced that Rod Hochman, M.D., president and CEO, moved into his role as the American Hospital Association’s board chair for 2021.

Partnership to Accelerate Adoption of Next-Generation Sequencing (NGS) in Clinical Decision-Making Comprehensive Pan-Cancer Tumor Profiling Assays can be Combined with Clinical Informatics Platform with Potential to Reduce Time to Results and Complexity of Clinical Genomic Analysis

Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum ™ Accepted for Review by the National Medical Products Administration in China Clinical trial expected to be initiated shortly after NMPA approval of the IND Sesen Bio to receive $3M milestone payment upon IND approval

SCHOTT continues to produce record-breaking numbers of pharmaceutical containers, including critical glass vials, as the U.S. prepares for COVID-19 vaccine distribution.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced it has entered into a securities purchase agreement with two institutional investors including a high-net-worth family office for the purchase and sale of 4,437,870 shares of common stock at a purchase price of $3.38 per share for gross proceeds of approximately $15.0 million in a registered direct offering priced above-the-market under Nasdaq rules

SleepScore Labs, the Sleep Science Company behind the world’s most comprehensive suite of data-backed sleep solutions, continues to lead the way in applied sleep research, highlighted with their latest product validation study of EyeJust Blue Light Filtering Screen Protectors for iPads and MacBooks.

Company Expects to Exceed Previously Announced Guidance Across All Key Metrics; Provides Full Year 2021 Guidance and Updates Long-Term Targets 2020 Total Product Bookings Expected to be Approximately $1.00 Billion and 2020 Revenues Expected to be $890 Million-$892 Million Increased Full Year 2021 Preliminary Revenue Guidance to $1.085 Billion-$1.105 Billion

Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second half of 2020 will support the Company in achieving its 2021 goals.

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations), announces today that it has signed a new distribution agreement with L1 Enterprises, a leading provider of medical equipment and supplies to the government marketplace including the Department of Defense (DOD), Department of Veterans Affairs (

Evoke Pharma, Inc. (“Evoke” or the “Company”) (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced positive findings from the first market research for GIMOTI following its launch during the fourth quarter of 2020. During December 2020, Evoke through its marketing partner, EVERSANA, conducted an ATU (Awareness, Trial, and Usage) Study, a quantitative s